-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Safety of 2-(4-Fluoro-phenyl)-piperazine in the Chemical Industry: A Comprehensive Overview
2-(4-Fluoro-phenyl)-piperazine is a chemical compound that is commonly used in the production of various pharmaceutical and industrial products.
Due to its unique properties, it has found application in the production of anti-inflammatory drugs, insecticides, and other chemicals.
However, the safety of this compound has been a subject of concern for many years.
In this article, we will comprehensively analyze the safety of 2-(4-fluoro-phenyl)-piperazine and its implications for the chemical industry.
The Safety Concerns of 2-(4-Fluoro-phenyl)-piperazine
2-(4-Fluoro-phenyl)-piperazine is known to have several safety concerns associated with its use.
The compound is considered a potential human carcinogen by the International Agency for Research on Cancer (IARC).
It has been found to cause liver and kidney damage in animal studies.
Additionally, it has been associated with reproductive and developmental toxicity in rats and mice.
The potential health risks of 2-(4-fluoro-phenyl)-piperazine have raised concerns about its safe handling and use in the chemical industry.
The compound is known to be highly toxic to aquatic life and it is also considered a potential danger to human health if proper safety measures are not adhered to during its production and use.
The Regulatory Framework Governing the Use of 2-(4-Fluoro-phenyl)-piperazine
The safety of 2-(4-fluoro-phenyl)-piperazine is regulated by various government agencies around the world.
The United States Environmental Protection Agency (EPA) has classified the compound as a probable human carcinogen.
The European Union has also designated the compound as a substance of very high concern (SVHC) and it is subject to authorization under the European Union's Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation.
In addition to the regulatory framework, various safety guidelines have been developed by various organizations to ensure the safe handling and use of 2-(4-fluoro-phenyl)-piperazine.
The National Institute for Occupational Safety and Health (NIOSH) has developed a recommended exposure limit (REL) for the compound.
The International Chemical Safety C